Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions for the study, broadening the potential population the page pertains to. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the site revision banner updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T13:41:29.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 removed, indicating a version update that does not change study details or how the page is used.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, replacing the previous revision entry.
    Difference
    0.0%
    Check dated 2026-01-15T05:09:37.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    A new consolidated Locations section lists participating sites across California, Colorado, Kentucky, Michigan, New York, Pennsylvania, South Dakota, Texas, and Utah, replacing the prior per-state headings. The footer revision note also updates from v3.3.2 to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-17T19:45:42.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed on the page, replacing v3.2.0. This update is limited to a software/version change and does not alter study details or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:59:24.000Z thumbnail image

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.